Subsequently, we tested the hypothesis that increased TAGLN2 expression may contribute to worse prognoses in IDH1/2 WT gliomas by investigating the role and regulation of TAGLN2 regulation in both LGGs and GBMs. This evidence concerns the gene IDH1 and central nervous system cancer.